Fiches Amavita / Sun Store / Coop Vitality
Details
- Product number
- 3620302
- CPT
- -
- Packaging group
- 20
- Unit
- Tablette(n)
- Composition
- lorazepamum 2.5 mg, lactosum monohydricum 132.925 mg, cellulosum microcristallinum, polacrilinum kalicum, magnesii stearas, E 104, E 172, pro compresso.
Articles (1)
Temesta 2.5mg, Tabletten
Tabletten
20
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
lorazepamum
|
2.5 MG | Substance | Wirkstoff (Principe actif) |
|
lactosum monohydricum
|
132.925 MG | Substance | HBESI |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
polacrilinum kalicum
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
|
E 104
|
- | Substance | FIMDK |
|
E 172
|
- | Substance | FTODK |
Reimbursement information
Public price
CHF 13.15
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
15/03/1975
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 36203
- Drug name
- Temesta, Tabletten
- Galenic form
- TAB
- ATC Code
- N05BA06
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 18/09/1973
- Authorization expiration date
- 31/12/9999
- IT number
- 01.04.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TEMESTA cpr 2.5 mg 20 pce
- Description (DE)
- TEMESTA Tabl 2.5 mg 20 Stk
- Market launch
- 18/09/1973
- Narcotic (BTM)
- B